What were Suven Life Sciences Ltd's latest quarterly results?
Suven Life Sciences Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: -161.5%
- Revenue Growth YoY: +50.0%
- Operating Margin: -3678.0%
Suven Life Sciences Ltd: Stock Analysis & Fundamentals
Updated this weekSuven Life Sciences Ltd (Pharma - Formulators) — fundamental analysis, earnings data, and key metrics. ROE: -87.2%. This stock is not currently in the Nifty 500 momentum outperformers list.
What's Happening
👔Promoter stake down 2.9% this quarter
🌐FII stake increased 0.8% this quarter
🏛️DII accumulation — stake up 2.3%
Key Numbers
Current Price
₹130
Market Cap
3.4K Cr
Valuation
N/AOther Top Pharma - Formulators Stocks Beating Nifty 500
Frequently Asked Questions: Suven Life Sciences Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Suven Life Sciences Ltd's price-to-book ratio?
Suven Life Sciences Ltd's price-to-book ratio is 10.5x.
- Price-to-Book (P/B): 10.5x
- Book Value per Share: ₹12
- Current Price: ₹130
Is Suven Life Sciences Ltd a fundamentally strong company?
Suven Life Sciences Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): -87.0%
Is Suven Life Sciences Ltd debt free?
Suven Life Sciences Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹0 Cr
What is Suven Life Sciences Ltd's return on equity (ROE) and ROCE?
Suven Life Sciences Ltd's return ratios over recent years
- FY2023: ROCE -53.0%
- FY2024: ROCE -36.0%
- FY2025: ROCE -87.0%
Is Suven Life Sciences Ltd's cash flow positive?
Suven Life Sciences Ltd's operating cash flow is negative (FY2025).
- Cash from Operations (CFO): ₹-154 Cr
- Free Cash Flow (FCF): ₹1 Cr
What is Suven Life Sciences Ltd's dividend yield?
Suven Life Sciences Ltd currently does not pay a significant dividend (yield 0.00%).
- Dividend Yield: 0.00%
- Current Price: ₹130
Who holds Suven Life Sciences Ltd shares — promoters, FII, DII?
Suven Life Sciences Ltd's shareholding pattern (Mar 2026)
- Promoters: 70.2%
- FII (Foreign): 0.8%
- DII (Domestic): 4.6%
- Public: 24.4%
Is promoter holding increasing or decreasing in Suven Life Sciences Ltd?
Suven Life Sciences Ltd's promoter holding has increased recently.
- Current Promoter Holding: 70.2% (Mar 2026)
- Previous Quarter: 67.4% (Dec 2025)
- Change: +2.79% (increasing — positive signal)
Is Suven Life Sciences Ltd a new momentum entry or an established outperformer?
Suven Life Sciences Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Suven Life Sciences Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Suven Life Sciences Ltd may be worth studying
- Currently showing mixed signals — monitor for clearer trend confirmation
What is the investment thesis for Suven Life Sciences Ltd?
Suven Life Sciences Ltd investment thesis summary:
What is the future outlook for Suven Life Sciences Ltd?
Suven Life Sciences Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.